Funded Tech Companies
Neuvivo
Neuvivo, operating out of Palo Alto, received equity investments from Primestreet Capital.
Company Overview
Company Name
Neuvivo
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
530 Lytton Ave 214
Palo Alto, CA 94301
USA
Palo Alto, CA 94301
USA
Phone
Website
Email Address
Company Background Information
Overview
Neuvivo is dedicated to creating therapeutics for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative diseases. We are investigating a patented macrophage-targeted technology, NP001, designed to address chronic inflammation, a key factor in the progressive loss of motor function in ALS. To date, the treatment has received Orphan Drug and Fast Track designation by the FDA as it addresses a clear unmet medical need. We are diligently working to move this compound toward regulatory approval, with the goal of delivering an effective new treatment to reduce the suffering caused by ALS.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
6/15/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Arasteh Azhir
Chief Financial Officer
Bruce Kaufman
Chief Medical Officer
Bruce Forrest
Chief Scientific Officer
Michael McGrath
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs